New Posts New Posts RSS Feed - IL-7 (CYT107) And XELODA (Capecitabine) Trial
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

IL-7 (CYT107) And XELODA (Capecitabine) Trial

 Post Reply Post Reply
Author
123Donna View Drop Down
Senior Member
Senior Member
Avatar

Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13209
Post Options Post Options   Thanks (0) Thanks(0)   Quote 123Donna Quote  Post ReplyReply Direct Link To This Post Topic: IL-7 (CYT107) And XELODA (Capecitabine) Trial
    Posted: May 12 2011 at 7:54am

Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine) Combination In Treatment Of Metastatic Breast Cancer


Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard (Lyon), the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS (Grenoble), a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7 (CYT107), the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA (R) (capecitabine, Roche/Genentech), in the treatment of metastatic breast cancer.

To read the entire article:
http://www.medicalnewstoday.com/releases/224967.php

DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09)
11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15

Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down

Forum Software by Web Wiz Forums® version 12.01
Copyright ©2001-2018 Web Wiz Ltd.